Edel del
Barco Morillo
Profesor Asociado CC. Salud
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (10)
2023
-
Real-world treatment patterns and survival outcomes for patients with stage III non-small cell lung cancer in Spain: a nationwide cohort study
Translational Lung Cancer Research, Vol. 12, Núm. 10, pp. 2113-2128
2022
2021
-
Lung cancer patients with COVID-19 in Spain: GRAVID study
Lung Cancer, Vol. 157, pp. 109-115
-
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer, Vol. 21, Núm. 1
2020
2019
-
Lung cancer in Spain: Information from the Thoracic Tumors Registry (TTR study)
Translational Lung Cancer Research, Vol. 8, Núm. 4, pp. 461-475
2017
-
Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study
International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 3, pp. 473-480
2016
-
A Phase 2 Open Label, Single-Arm Trial to Evaluate the Combination of Cetuximab Plus Taxotere, Cisplatin, and 5-Flurouracil as an Induction Regimen in Patients with Unresectable Squamous Cell Carcinoma of the Head and Neck
International Journal of Radiation Oncology Biology Physics, Vol. 94, Núm. 2, pp. 289-296
2013
-
SEOM clinical guidelines for the treatment of head and neck cancer (HNC) 2013
Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 1018-1024
-
SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013
Clinical and Translational Oncology, Vol. 15, Núm. 12, pp. 1025-1029